WeightWatchers’ CEO embraced Ozempic. Now she’s out of the company.
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
Read More from the Global Wellness News ™
- L Catterton Acquires Majority Stake in Solidcore Amid Pilates Boom
- Wood waste and bioplastic floor panel boasts the strength of steel